Skip to content
Discover professional insights on diamond identification, v…

Prestigious Prize Honors Groundbreaking Body's Defenses Discoveries

The Nobel Prize in medical science was granted for transformative discoveries that illuminate how the body's defense network targets dangerous pathogens while protecting the healthy tissues.

A trio of renowned scientists—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this honor.

The research identified unique "security guards" within the immune system that remove malfunctioning immune cells that could attacking the organism.

The discoveries are now paving the way for new treatments for immune disorders and malignancies.

These winners will divide a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"Their research has been decisive for comprehending how the body's defenses operates and the reason we don't all develop serious autoimmune diseases," stated the head of the Nobel Committee.

The team's studies explain a fundamental mystery: How does the defense system protect us from countless invaders while leaving our own tissues unharmed?

Our immune system employs immune cells that search for signs of infection, including viruses and germs it has not met before.

Such defenders utilize sensors—called receptors—that are generated by chance in countless combinations.

That gives the defense network the capacity to combat a wide array of threats, but the randomness of the mechanism inevitably creates immune cells that can target the body.

Protectors of the Immune System

Researchers previously understood that a portion of these harmful white blood cells were eliminated in the immune organ—where immune cells develop.

This year's award recognizes the identification of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize other defenders that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel added, "These findings have laid the foundation for a new field of investigation and spurred the development of new treatments, for instance for tumors and immune disorders."

Regarding malignancies, regulatory T-cells block the body from fighting the tumor, so research are focused on lowering their numbers.

In self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer being harmed. A comparable approach could also be effective in reducing the chances of organ transplant rejection.

Innovative Studies

Prof Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.

He showed that injecting immune cells from other animals could prevent the disease—suggesting there was a system for blocking defenders from attacking the host.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a gene vital for the way T-regs function.

"Their pioneering work has revealed how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a leading biological science expert.

"The work is a striking example of how basic physiological research can have far-reaching implications for public health."

By

Tony Wong

A certified gemologist with over 15 years of experience in diamond grading and international gem markets, specializing in rare stone authentication.

Diamond Finder

Type to search articles.